CompletedNCT05117775

Towards A Better Paradigm for Head and Neck Cancer Treatment Applying Artificial Intelligence: an International Cohort Study of Electronic Health Records. HNC-TACTIC.

Sponsor: Savana Research

Trial Details

Condition	Head and Neck Cancer
Intervention	No intervention - Just description and predictive models
Status	Completed
Participants	10,000
Est. Completion	28 Feb 2024
Last Updated	1 May 2026

Primary Outcome

Predictive model based on dynamic risk stratification (DRS) for the risk of recurrence or disease progression; Predictive model based on dynamic risk stratification (DRS) aimed at identifying patients' features

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: * Patients ≥18 years old. * Patients diagnosed with HNSCC * For selected exploratory analyses, patients diagnosed with nasopharynx, paranasal sinus, and salivary gland tumors. Exclusion Criteria: * Patients with follow-up of less than 6 months, except if deceased (any cause) in the 6 months after HNSCC diagnosis

Trial Sites

Countries

Spain

View Registry Entry

Related Analysis

Completed International Study Reveals AI-Driven Risk Stratification Models for Head and Neck Cancer — Clinical Practice Implications

The completed HNC-TACTIC study analysed 10,000 head and neck cancer patients using advanced natural language processing to develop predictive models for disease recurrence and progression. These findings could transform clinical decision-making in head and neck oncology through improved risk stratification.

Read full article →

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service